Malignant hyperthermia in pregnancy.
D000284:Administration, Oral; D000773:Anesthesia, Obstetrical / Q000009:adverse effects*; D002585:Cesarean Section; D003620:Dantrolene / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008305:Malignant Hyperthermia / Q000517:prevention & control / Q000628:therapy; D011247:Pregnancy; D013997:Time Factors
D003620:Dantrolene